Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerolamo Antonio Pirisino is active.

Publication


Featured researches published by Gerolamo Antonio Pirisino.


Aaps Pharmscitech | 2000

Evaluation of alginate compressed matrices as prolonged drug delivery systems

Paolo Giunchedi; Elisabetta Gavini; Mario Domenico Luigi Moretti; Gerolamo Antonio Pirisino

This research investigated the use of sodium alginate for the preparation of hydrophylic matrix tablets intended for prolonged drug release using ketoprofen as a model drug. The matrix tablets were prepared by direct compression using sodium alginate, calcium gluconate, and hydroxypropylmethylcellulose (HPMC) in different combinations and ratios. In vitro release tests and erosion studies of the matrix tablets were carried out in USP phosphate buffer (pH 7.4). Matrices consisting of sodium alginate alone or in combination with 10% and 20% of HPMC give a prolonged drug release at a fairly constant rate. Incorporation of different ratios of calcium gluconate leads to an enhancement of the release rate from the matrices and to the loss of the constant release rate of the drug. Only the matrices containing the highest quantity of HPMC (20%) maintained their capacity to release ketoprofen for a prolonged time.


Journal of Microencapsulation | 2001

Spray-dried microspheres containing ketoprofen formulated into capsules and tablets

Mario Domenico Luigi Moretti; Elisabetta Gavini; Claudia Clelia Assunta Juliano; Gerolamo Antonio Pirisino; Paolo Giunchedi

In this study, microspheres were prepared by a spray-drying technique using solutions of ketoprofen and two polymers, cellulose acetate butyrate (CAB) and hydroypropylmethylcellulose phthalate (HPMCP), in different weight ratios. Different total concentrations were used in the feed solutions: 3, 6 and 9% w/v. The spray-dried microparticles were characterized in terms of shape (SEM), size (light scattering method), production yield and encapsulation efficiency. They were formulated into capsules; tablets were prepared by direct compression of the microparticles mixed with maltose and, in some cases, hydroypropylmethylcellulose (HPMC). In vitro release studies were performed both at acidic and neutral pHs. The spray-drying process of solutions of ketoprofen with polymeric blends of cellulose derivatives leads to microparticles which, depending on their final formulation (capsules or tablets), can give a rapid or prolonged drug release. The formulations here described can be proposed for the oral administration of NSAIDs.In this study, microspheres were prepared by a spray-drying technique using solutions of ketoprofen and two polymers, cellulose acetate butyrate (CAB) and hydroypropylmethylcellulose phthalate (HPMCP), in different weight ratios. Different total concentrations were used in the feed solutions: 3, 6 and 9% w/v. The spray-dried microparticles were characterized in terms of shape (SEM), size (light scattering method), production yield and encapsulation efficiency. They were formulated into capsules; tablets were prepared by direct compression of the microparticles mixed with maltose and, in some cases, hydroypropylmethylcellulose (HPMC). In vitro release studies were performed both at acidic and neutral pHs. The spray-drying process of solutions of ketoprofen with polymeric blends of cellulose derivatives leads to microparticles which, depending on their final formulation (capsules or tablets), can give a rapid or prolonged drug release. The formulations here described can be proposed for the oral administration of NSAIDs.


Archiv Der Pharmazie | 2000

Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems

Elisabetta Gavini; Claudia Clelia Assunta Juliano; Antonio Calogero Mulè; Gerolamo Antonio Pirisino; Gabriele Murineddu; Gérard Aimé Pinna

A number of 9H‐indeno[2,1‐c]pyridazine N‐oxides (3a—c) and benzo[f]cinnoline N‐oxides (4,5a—c) have been synthesized and tested for antimicrobial activity. All new products were inactive against Gram negative bacteria and fungi. In contrast, among the compounds synthesized, 3b, 4b and 5b showed a moderate activity against Gram positive Staphylococcus aureus and Staphylococcus epidermidis. Of the present series, the 9‐nitro‐benzo[f]cinnoline N‐oxide 5b possessed the highest activity especially against Trichomonas vaginalis (MIC = 3.9 μg/ml).


Farmaco | 1992

Synthesis and pharmacological activity of 4-carbamoyl-5-aryl-6-methyl-4,5-dihydropyridazin-3 (2H)-ones

Gérard Aimé Pinna; Maria Michela Curzu; Elisabetta Gavini; Antonio Calogero Mulè; Gerolamo Antonio Pirisino; M. Satta; Peana A

A new series of 4-carbamoyl-5-aryl-6-methyl-4,5-dihydropyridazin-3(2H)-ones have been synthesized and tested for their antiinflammatory and analgesic properties. Amongst the test compounds, only 31 showed antiinflammatory activity, though of shorter duration than that of indomethacin, taken as reference drug. On the contrary, many derivatives displayed relevant analgesic activity, 4--the only 4,5-dehydroderivative--being the most potent in the writhing test. In the hot plate test 3b, 3f and 3k were found to possess the most significant analgesic properties.


ChemInform | 1981

1,6-DISUBSTITUTED 3-METHYLQUINOXALIN-2(1H)-ONES. EFFECTS ON INITIATION AND MODIFICATION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS

M. C. Alamanni; Gerolamo Antonio Pirisino; F. Savelli; Fabio Sparatore; P. Manca; M. Satta

Die o-Halogennitro-benzole (I) reagieren mit Diaminen (II) zu den Nitro-anilinen (III), aus denen durch Hydrierung die o-Phenylendiamine (IV) und durch darauffolgende Kondensation mit Brenztraubensaureethylester (V) die Chinoxalinone (VI) erhalten werden.


International Journal of Pharmaceutics | 2006

Nasal administration of Carbamazepine using chitosan microspheres : In vitro/in vivo studies

Elisabetta Gavini; Anne Bee Hegge; Gloria Rassu; Vanna Sanna; Cecilia Testa; Gerolamo Antonio Pirisino; Jan Karlsen; Paolo Giunchedi


Farmaco | 1989

[1,4-Disubstituted 1,3-dihydro-2H-1,5-benzo- and chlorobenzodiazepin-2-ones with activity on the central nervous system].

Savelli F; Boido A; Antonio Calogero Mulè; Piu L; Alamanni Mc; Gerolamo Antonio Pirisino; Satta M; Peana A


Farmaco | 1997

Pyridazine N-oxides. II. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides.

Elisabetta Gavini; Claudia Clelia Assunta Juliano; Antonio Calogero Mulè; Gerolamo Antonio Pirisino; Gérard Aimé Pinna


Farmaco | 1996

Pyridazine N-oxides. I. Synthesis and in vitro antimicrobial evaluation of 3-methyl-4-aryl-6-R-pyridazine N-oxides

Elisabetta Gavini; Claudia Clelia Assunta Juliano; Antonio Calogero Mulè; Gerolamo Antonio Pirisino; Gérard Aimé Pinna; Maria Michela Curzu


Farmaco | 1992

Antispasmodic activity of tert-aminoalkylderivatives of 3-benzyl-, 3-benzylaza- and 3-benzyldiazaquinoxalinones.

Paola Manca; Peana A; Savelli F; Antonio Calogero Mulè; Gerolamo Antonio Pirisino

Collaboration


Dive into the Gerolamo Antonio Pirisino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge